Role of Caffeine in the Age-related Neurodegenerative Diseases: A Review
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60162694%3AG44__%2F23%3A00558405" target="_blank" >RIV/60162694:G44__/23:00558405 - isvavai.cz</a>
Výsledek na webu
<a href="https://www.eurekaselect.com/article/122525" target="_blank" >https://www.eurekaselect.com/article/122525</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2174/1389557522666220413103529" target="_blank" >10.2174/1389557522666220413103529</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Role of Caffeine in the Age-related Neurodegenerative Diseases: A Review
Popis výsledku v původním jazyce
Caffeine, a simple purine alkaloid with the proper chemical name 1,3,7-trimethylpurine-2,6-dione, is an abundant compound present in coffee, food and drugs. It interacts with various pathways of which antagonism of adenosine receptors is the most significant but the other physiological pathways can be influenced by caffeine as well. Interaction with glutamate and dopamine neurotransmission pathways, competition with other substrates on cytochrome P450, non-competitive inhibition of acetylcholinesterase, blocking of nicotinic acetylcholine receptor and competitive inhibition of cyclic nucleotide phosphodiesterase can be mentioned. Because of caffeine availability in foods, beverages and drugs, it has practical relevance even if the effect is weak. Intake of coffee containing edibles for a long period or even for a substantial part of life makes caffeine ' s impact significant. Low acute and chronic toxicity of caffeine is another important specification. The discoveries from the last few years point to the fact that caffeine would interfere with the progression of some age-related neurodegenerative disorders like Alzheimer's and Parkinson's diseases and dementia with Lewy bodies. In this review article, the recent findings about caffeine ' s impact on neurodegenerative diseases are presented and important facts about the caffeine effect, including the substantial discoveries, are described.
Název v anglickém jazyce
Role of Caffeine in the Age-related Neurodegenerative Diseases: A Review
Popis výsledku anglicky
Caffeine, a simple purine alkaloid with the proper chemical name 1,3,7-trimethylpurine-2,6-dione, is an abundant compound present in coffee, food and drugs. It interacts with various pathways of which antagonism of adenosine receptors is the most significant but the other physiological pathways can be influenced by caffeine as well. Interaction with glutamate and dopamine neurotransmission pathways, competition with other substrates on cytochrome P450, non-competitive inhibition of acetylcholinesterase, blocking of nicotinic acetylcholine receptor and competitive inhibition of cyclic nucleotide phosphodiesterase can be mentioned. Because of caffeine availability in foods, beverages and drugs, it has practical relevance even if the effect is weak. Intake of coffee containing edibles for a long period or even for a substantial part of life makes caffeine ' s impact significant. Low acute and chronic toxicity of caffeine is another important specification. The discoveries from the last few years point to the fact that caffeine would interfere with the progression of some age-related neurodegenerative disorders like Alzheimer's and Parkinson's diseases and dementia with Lewy bodies. In this review article, the recent findings about caffeine ' s impact on neurodegenerative diseases are presented and important facts about the caffeine effect, including the substantial discoveries, are described.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30107 - Medicinal chemistry
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2022
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Mini-Reviews in Medicinal Chemistry
ISSN
1389-5575
e-ISSN
1875-5607
Svazek periodika
22
Číslo periodika v rámci svazku
21
Stát vydavatele periodika
AE - Spojené arabské emiráty
Počet stran výsledku
10
Strana od-do
2726-2735
Kód UT WoS článku
000864627500004
EID výsledku v databázi Scopus
2-s2.0-85138884775